Matthijs Glastra - Jan 2, 2024 Form 4 Insider Report for NOVANTA INC (NOVT)

Signature
/s/ John Burke, Attorney-in-Fact
Stock symbol
NOVT
Transactions as of
Jan 2, 2024
Transactions value $
-$2,398,213
Form type
4
Date filed
1/4/2024, 04:40 PM
Previous filing
Dec 15, 2023
Next filing
Feb 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NOVT Common Stock Sale -$421K -2.57K -16.92% $163.65 12.6K Jan 2, 2024 Direct F1, F2
transaction NOVT Common Stock Sale -$248K -1.51K -11.94% $164.37 11.1K Jan 2, 2024 Direct F1, F3
transaction NOVT Common Stock Sale -$69.8K -420 -3.78% $166.24 10.7K Jan 2, 2024 Direct F1, F4
transaction NOVT Common Stock Sale -$83.3K -500 -4.67% $166.64 10.2K Jan 2, 2024 Direct F1
transaction NOVT Common Stock Award $0 +21.5K +210.86% $0.00 31.7K Jan 2, 2024 Direct F5
transaction NOVT Common Stock Tax liability -$1.58M -9.59K -30.25% $164.30 22.1K Jan 2, 2024 Direct
holding NOVT Common Stock 63.9K Jan 2, 2024 Matthijs Glastra 2021 Irrevocable Trust
holding NOVT Common Stock 27.7K Jan 2, 2024 Anna Maria Vogelaar 2020 Trust
holding NOVT Common Stock 27.7K Jan 2, 2024 Matthijs Glastra 2023 GRAT
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2023.
F2 This transaction was executed in multiple trades at prices ranging from $163.15 to $164.14. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F3 This transaction was executed in multiple trades at prices ranging from $164.17 to $164.67. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F4 This transaction was executed in multiple trades at prices ranging from $165.58 to $166.57. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F5 Represents the number of Novanta Inc. common shares earned pursuant to the terms of a performance stock unit award granted on February 24, 2021, reflecting the achievement of applicable relative total shareholder return (TSR) performance conditions over a three-year period from fiscal 2021 through fiscal 2023.

Remarks:

Power of Attorney on file